This page is for everyone who wants to understand what skull base Surgery involves, what the different surgical approaches look like, and what high-quality specialist care in this field actually means.
Skull base Surgery refers to surgical procedures performed at the base of the skull — the bony floor of the cranial cavity that separates the brain from the face, the nose, and the throat. Tumours can arise from this region itself, or they can grow upward from the nasal cavity, the sinuses, or the upper throat, eventually involving the skull base.
The skull base is not one single structure — it has three distinct regions known as the anterior, middle, and posterior cranial fossa, each harbouring different anatomical structures and, consequently, different types of tumours.
Meningiomas, pituitary adenomas, chordomas, esthesioneuroblastomas, craniopharyngiomas, and sinonasal malignancies that extend upward are among the conditions that bring patients to a skull base surgeon.
What makes Surgery in this region so technically demanding is the density of critical structures. The optic nerves, the facial nerve, the auditory nerve, the carotid artery, and multiple other cranial nerves all pass through or near the skull base.
Surgery here is, in a very real sense, a conversation between the surgeon’s hands and the anatomy — and a misstep can have permanent consequences.
This is why skull base Surgery is one of the most specialised fields in all of oncological Surgery — and why patients deserve access to a surgeon with dedicated training and experience in this exact domain.
Endoscopic skull base Surgery has fundamentally changed what is possible in this field over the last two decades. Where surgeons once had to make large incisions and move through the brain or the side of the face to reach tumours at the skull base, modern endoscopic techniques allow access through the natural corridors of the body — primarily the nasal passage.
An endoscope is a thin, rigid telescope with a light and camera at its tip. In endoscopic skull base Surgery, this instrument is passed through the nostrils, providing a magnified, high-definition view of the tumour and the surrounding anatomy — without a single external incision.
Surgeons work through the nostril, guided by real-time imaging, to remove tumours that were once considered inaccessible by any route other than open craniotomy.
For the right patient with the right tumour, endoscopic skull base Surgery is not just a less invasive option. It is often the superior one.
I perform endoscopic skull base Surgery as part of my specialist practice, applying this approach to anterior skull base tumours, pituitary adenomas, and selected sinonasal malignancies that extend to the skull base.
Every case is assessed individually to determine whether an endoscopic, open, or combined approach best serves the patient.
The transnasal endoscopic approach — also called the extended endoscopic endonasal approach — is the most widely used corridor in modern skull base Surgery for anterior and central skull base tumours.
As the name suggests, the surgical instruments travel through the nose, through the back wall of the nasal cavity, and directly to the tumour.
For patients, the most striking thing about this approach is what it avoids: there is no incision on the face or scalp, no retraction of the brain, and no disruption of the skin, bone, or muscle overlying the tumour.
The surgeon reaches the skull base entirely through the body’s own natural pathways.
These tumours sit in the midline of the skull base and are most directly accessed from below, through the nose.
In skilled hands, this approach achieves complete tumour removal with preservation of surrounding structures at rates comparable to, and in many cases exceeding, traditional open approaches.
The phrase minimally invasive skull base Surgery encompasses a broader set of approaches — all united by the principle that a smaller surgical footprint should not mean a less complete oncological result.
What these approaches share is an emphasis on accessing the tumour through the most direct and least disruptive route possible.
Advanced intraoperative imaging, neuronavigation systems that map the surgical field in real time, and high-definition endoscopic optics mean that surgeons today can achieve the kind of precision that once required much larger exposures.
For patients, minimally invasive skull base Surgery typically means shorter hospital stays, faster return to daily life, and — most importantly — a lower risk of complications affecting vision, hearing, facial movement, and cognition.
These are not marginal differences. In a region as delicate as the skull base, the difference between a small and a large surgical exposure can be the difference between a patient who recovers fully and one who does not.
For benign tumours such as meningiomas and pituitary adenomas, the goal of skull base tumour removal is complete resection — removing the entire tumour — while preserving the function of every surrounding structure.
When complete removal is not safely achievable, a subtotal resection followed by radiation therapy may represent the better oncological strategy.
For malignant tumours — sinonasal carcinomas, olfactory neuroblastomas, skull base chordomas, and others — the surgical goal remains complete resection with clear margins, but the planning process is more complex, often requiring preoperative discussion with radiation and medical oncologists about the role of adjuvant treatment.
In my practice, every skull base case is reviewed at a multidisciplinary tumour board before Surgery. The imaging is scrutinised by neuroradiology. The pathology, where available, is reviewed.
The surgical approach — endoscopic, open, or combined — is determined by the team, not by any single surgeon’s preference.
The cranial nerves are the body’s most important functional cables — responsible for sight, hearing, smell, taste, facial movement, swallowing, and voice.
Several of these nerves pass directly through or alongside the skull base, and their preservation during tumour removal is not a secondary goal. It is the primary measure of surgical quality.
Cranial nerve preservation requires a surgeon who understands the anatomy in three dimensions, who uses intraoperative neurophysiological monitoring to track nerve function during the operation in real time, and who has the technical discipline to slow down, change approach, or accept a smaller resection when a nerve is at risk.
And they should expect a clear, honest answer — one grounded in the surgeon’s experience with this specific type of tumour in this specific location.
I use intraoperative nerve monitoring as a standard part of skull base Surgery, and cranial nerve preservation is a metric I measure and take seriously in every case.
Removing the tumour completely matters enormously. But how a patient wakes up matters just as much.
When a skull base tumour is removed, the surgical defect that remains must be reconstructed.
This is not a minor detail — it is an essential step that prevents serious complications such as cerebrospinal fluid (CSF) leakage into the nasal cavity, meningitis, and wound breakdown.
Skull base reconstruction involves restoring the barrier between the brain and the nasal or sinus cavity.
The gold standard for endoscopic skull base reconstruction is the pedicled nasoseptal flap — a vascularised flap of tissue harvested from the nasal septum and rotated to cover the skull base defect.
For larger defects or open approaches, free tissue transfer or the use of synthetic dural substitutes may be required.
As a surgeon trained in both head and neck Oncology and microvascular reconstruction, I approach skull base reconstruction as an integral part of the operative plan, not an afterthought.
The reconstruction is planned before the Surgery begins, ensuring that the tissue and materials needed are available and that the defect, whatever its size, can be reliably closed.
Among the many conditions that bring patients to a skull base surgeon, pituitary adenomas and meningiomas are the two most frequently encountered.
The pituitary gland sits at the centre of the skull base, in a bony recess called the sella turcica.
Tumours arising from the pituitary — called pituitary adenomas — can cause problems either by growing large enough to compress the surrounding structures, particularly the optic chiasm, leading to visual field loss, or by secreting hormones in excess, causing conditions such as Cushing’s disease, acromegaly, or hyperprolactinaemia.
The transnasal endoscopic approach is the standard of care for most pituitary adenomas, allowing complete tumour removal through the nostrils without any external incision.
Recovery is typically rapid, and the majority of patients experience significant improvement in their symptoms and hormonal function after Surgery.
Meningiomas are tumours of the meninges — the membranes that surround the brain and spinal cord.
When they arise at the skull base, they can involve the optic nerves, the cavernous sinus, the internal carotid artery, or the posterior fossa, making their removal technically demanding.
Skull base meningiomas require careful preoperative planning with detailed MRI and CT angiography.
The surgical approach — which may be endoscopic, open, or combined — is chosen based on the tumour’s location, its relationship to the cranial nerves, and the degree of vascular involvement.
In selected cases, radiosurgery (stereotactic radiation) may be recommended alongside or instead of Surgery.
Skull base Surgery is never the work of a single surgeon. The complexity of these cases demands a multidisciplinary skull base team — a group of specialists who bring complementary expertise to the same patient, at the same table, before any decision is finalised.
Together, they review the imaging, the biopsy findings, the patient’s functional status, and the available treatment options — and arrive at a plan that no single specialist would have reached alone.
This multidisciplinary skull base team approach is not a formality. It is the reason that outcomes at specialist skull base programmes are consistently better than those achieved in centres where these cases are managed by a single specialty.
Patients with skull base tumours deserve this level of coordinated, expert attention — and it is the standard I hold myself and my team to.
Head and neck Oncology is a recognised surgical subspecialty — one that requires dedicated postgraduate training beyond a general ENT or neurosurgical qualification.
As Karnataka’s first certified head and neck Oncology surgeon, I bring a depth of subspecialty training to skull base cases that is specific to this field.
My training and practice have been built around the principle that the skull base — like the oral cavity, the larynx, and the thyroid — is a region where subspecialty expertise changes outcomes.
The surgeon’s understanding of the anatomy, the oncological principles, and the reconstructive options available matters more here than almost anywhere else in the body.
Patients with skull base tumours in Karnataka and across South India have historically had to travel to large metro centres for specialist care.
My practice exists to change that — to make expert skull base surgical care available at home, within a multidisciplinary framework, without compromising on quality.
We Are Here To Help With Your queries !
+91 95355 47980
Skull base tumours are usually identified on MRI or CT imaging, often ordered because of symptoms such as headaches, visual changes, facial numbness, hearing loss, or hormonal disturbances.
If imaging shows a tumour in or near the skull base, a consultation with a specialist in skull base surgery is the appropriate next step to understand what treatment is needed.
In experienced hands, endoscopic skull base surgery has an excellent safety record for appropriate tumours.
As with all surgery, risks exist — including CSF leak, bleeding, and very rarely cranial nerve injury — but these rates are consistently lower with endoscopic approaches compared to open craniotomy for tumours suitable for endonasal access.
It depends on the tumour type, the completeness of resection, and the pathology report.
Benign tumours that are completely removed often do not require radiation. Malignant tumours, incompletely resected meningiomas, and certain benign tumours with aggressive features may benefit from adjuvant radiotherapy or radiosurgery.
Recovery varies significantly depending on the surgical approach and the extent of the operation.
For transnasal endoscopic procedures, most patients are discharged within three to five days. Open approaches may require a longer hospital stay.
Full recovery — including return to work and normal activity — typically takes four to eight weeks, with ongoing follow-up imaging to monitor the surgical site.
If you or someone you love has questions on Cancer, please feel free to reach out to ARC Cancer Hospital — our team of Cancer specialists will make time to answer your questions and help you find the clearest path forward.
Dr Samskruthi P Murthy | Head & Neck Oncology Surgeon | ARC Cancer Hospital, Bengaluru, Karnataka
